Minnema M, Nasserinejad K, Hazenberg B, et al. HOVON 104: results from a multicenter, prospective phase II study of bortezomib based induction treatment followed by autoogous stem cell transplantation in patients with de novo AL amyloidosis. EHA 2017, abstract S411.
FDA geeft goedkeuring aan tisagenlecleucel voor behandeling acute lymfatische leukemie
sep 2017 | Leukemie